ATA Pushes Interstate Telehealth Back Onto the Federal Agenda

In a March 31 announcement, the American Telemedicine Association and Johns Hopkins Medicine launched the LIFTT initiative to push for targeted federal reforms that would ease cross state telehealth barriers without displacing state licensure authority. (ATA) The announcement reads like a policy campaign, but its deeper significance is simpler. Telehealth has already proven that it can extend clinical relationships, preserve specialist access, and reduce unnecessary travel. What it has not solved is the legal fragmentation that still determines whether a virtual visit is allowed once a patient crosses a state line.

That distinction matters because the telehealth debate has changed. The earlier fight was about payment, emergency waivers, and basic adoption. The current fight is about continuity. Once virtual care became a normal part of follow up, chronic disease management, behavioral health, oncology, transplant care, and second opinions, state by state licensure rules stopped looking like background regulation and started functioning like a direct access barrier. The ATA and Hopkins effort is important precisely because it acknowledges that telehealth is no longer waiting to prove its clinical relevance. It is running into the limits of a regulatory structure that was built for local, in person practice.

Telehealth Has Outgrown the Waiver Era

The federal government’s own guidance still makes the core problem clear. Telehealth.HHS.gov states that providers generally must be licensed in the state where the patient is located at the time of the appointment. (telehealth.hhs.gov) That rule is coherent from a state oversight perspective, but it creates a modern access problem that licensing law was never designed to handle well. A patient who leaves home for college, travels during treatment, relocates temporarily for family reasons, or seeks a rare specialist in another state may be clinically stable enough for virtual follow up and still lose access because the legal framework assumes geography should control the relationship.

The Johns Hopkins policy report behind this new push makes the case more directly. It argues that cross state licensure rules are now one of the main barriers to broader interstate telehealth, especially for continuity of care, rare expertise, and patients whose care trajectories already span institutions and state borders. (Johns Hopkins in Washington, D.C.) That is the real significance of this initiative. It treats telehealth not as a stand alone convenience service, but as infrastructure for maintaining clinical relationships that already exist.

There is also a timing issue. During the pandemic, temporary waivers showed what broader interstate access could look like. Once those waivers expired, many states returned to stricter licensing requirements, even though patient expectations and care models had already changed. The result is a familiar kind of policy lag, with clinical practice evolving faster than the legal assumptions around it. The waiver era demonstrated that a more flexible model was possible. The post waiver period has shown how incomplete the current settlement really is. (Johns Hopkins in Washington, D.C.)

The Compact Model Is Helpful but Incomplete

The strongest argument against federal action has been that interstate compacts already exist. That is true, but it is only a partial answer. Telehealth.HHS.gov’s compacts guidance explicitly describes licensure compacts as a faster pathway to interstate practice, not as a replacement for multistate licensing itself. (telehealth.hhs.gov) The Interstate Medical Licensure Compact has clearly scaled, and its FY2025 annual report says the compact now includes 44 member jurisdictions, serves more than 49,000 physicians, and reports that 54 percent of participating physicians intend to use their licenses in rural or underserved areas.

Those numbers are meaningful, but they do not eliminate the underlying burden. The compact accelerates paperwork and credential sharing. It does not create true portability. Physicians still need separate licenses, separate renewals, and separate compliance awareness across jurisdictions. The Hopkins analysis argues that this is why the compact, while useful, is not sufficient for the problem now in view. It streamlines administrative work, but it does not resolve the fact that continuity of care can still be disrupted when the patient is temporarily or permanently elsewhere. (Johns Hopkins in Washington, D.C.)

That gap becomes clearer when compared with the broader policy landscape. The Center for Connected Health Policy continues to document that no two states define and regulate telehealth in exactly the same way, and its current policy tracking shows that licensing exceptions, registration pathways, and cross state requirements remain highly variable. (Public Health Institute) In other words, the system has evolved into a patchwork of partial relief. Some states offer narrow exceptions. Others lean on compacts. Others preserve tighter restrictions. From a patient access perspective, that means the availability of virtual follow up often depends less on clinical appropriateness than on jurisdictional coincidence.

A Narrow Federal Fix Could Travel Further

The most pragmatic feature of the ATA and Hopkins initiative is that it does not call for full federal preemption of state licensure. It calls for narrow federal pathways that preserve state standards and disciplinary authority while allowing targeted forms of interstate care. (ATA) That is not a rhetorical compromise. It is probably the only politically plausible route.

The Hopkins team has already outlined two ideas that fit that narrower frame: a continuity of care model and a national telehealth registry. (Johns Hopkins in Washington, D.C.) The continuity model is the stronger concept because it addresses the most defensible cases first. Follow up care after an established in person or long term relationship is easier to justify than unrestricted national telepractice. It preserves the logic of licensure while acknowledging that modern care often unfolds across time, settings, and state borders. A registry could also help, but it raises more governance and operational questions about eligibility, enforcement, and scope.

That approach also tracks with what HHS policy analysis has already suggested in adjacent areas. A 2024 issue brief on interstate licensure portability for behavioral health practitioners concluded that federal action could help address oversight, financing, and implementation barriers without erasing the states’ public protection role. (ASPE) The telehealth licensure debate is often framed as a choice between state authority and access. In reality, the more plausible policy space lies between those poles.

That middle ground may also be where bipartisan support is most durable. Federal law already makes special accommodations in narrowly defined settings, and the history of interstate telehealth legislation shows recurring interest in targeted reciprocity rather than wholesale national licensure. The strategic logic of LIFTT is that a carefully bounded federal solution has a better chance of surviving than an attempt to rebuild professional licensure from the ground up.

The Patients Most Likely to Be Left Waiting

The most persuasive case for reform is not administrative simplification. It is patient mismatch. The current rules hit hardest where care is already scarce, specialized, or longitudinal. The ATA announcement and the Johns Hopkins materials repeatedly point to the same groups: patients with rare diseases or cancer, transplant recipients, college students receiving ongoing care away from home, people needing mental health treatment, clinical trial participants, and rural patients who are far from specialty centers. (ATA)

Those are not edge cases. They are the places where telehealth is most clinically rational and where fragmentation does the most damage. A patient traveling for oncology treatment may need follow up that does not justify another flight. A college student with an established psychiatrist may need continuity more than a local restart. A transplant recipient may need the original team’s oversight long after the hospitalization ends. In each case, the barrier is not the technology. It is the legal fiction that care remains local even when the health system does not.

That is why this initiative deserves serious attention. It suggests that telehealth policy is entering a more mature phase, one in which the central question is no longer whether virtual care works, but whether regulation can distinguish between meaningful oversight and preventable interruption. If the next phase of reform fails, telehealth will remain widely available and unevenly usable. The patients most likely to notice will be the ones whose care has the least room for delay.